Interferon beta gene therapy

Drug Profile

Interferon beta gene therapy

Latest Information Update: 03 Sep 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Transgene
  • Class Antivirals; Cytokine genes; Gene therapies; Interferons
  • Mechanism of Action Interferon beta stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Bladder cancer; HIV infections

Most Recent Events

  • 02 Dec 2002 Discontinued - Preclinical for Bladder cancer in USA (unspecified route)
  • 07 Mar 2002 Discontinued - Preclinical for HIV infections treatment in France (unspecified route)
  • 13 Jul 1999 Preclinical development for Bladder cancer in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top